Stock Track | Intuitive Surgical Plummets 5.04% Intraday on Price Target Cut and Product Recalls

Stock Track05-28 00:35

Intuitive Surgical's stock plummeted 5.04% during intraday trading on Wednesday, as the medical device company faced dual headwinds from analyst downgrades and product safety concerns.

The decline followed Goldman Sachs lowering its price target on Intuitive Surgical to $558 from $621, representing a reduction of approximately 10%, while maintaining a Buy rating on the shares. The average analyst price target for the stock stands at $575.70 with an overweight rating, according to FactSet data.

Simultaneously, the company is grappling with multiple ongoing voluntary product recalls affecting its da Vinci surgical systems. The U.S. FDA announced a Class I recall of SureForm 30 Gray Reloads due to incomplete staple lines, impacting products distributed both domestically and internationally. Additional recalls involve certain da Vinci X and Xi system sub-components over concerns about screws breaking within the arm sub-assembly, raising questions about product reliability and future regulatory oversight.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1174731879?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-28 00:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1174731879","market":"us","top_or_hot":-1,"title":"Stock Track | Intuitive Surgical Plummets 5.04% Intraday on Price Target Cut and Product Recalls","media":"Stock Track","content":"<p>Intuitive Surgical's stock plummeted 5.04% during intraday trading on Wednesday, as the medical device company faced dual headwinds from analyst downgrades and product safety concerns.</p><p>The decline followed Goldman Sachs lowering its price target on Intuitive Surgical to $558 from $621, representing a reduction of approximately 10%, while maintaining a Buy rating on the shares. The average analyst price target for the stock stands at $575.70 with an overweight rating, according to FactSet data.</p><p>Simultaneously, the company is grappling with multiple ongoing voluntary product recalls affecting its da Vinci surgical systems. The U.S. FDA announced a Class I recall of SureForm 30 Gray Reloads due to incomplete staple lines, impacting products distributed both domestically and internationally. Additional recalls involve certain da Vinci X and Xi system sub-components over concerns about screws breaking within the arm sub-assembly, raising questions about product reliability and future regulatory oversight.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Intuitive Surgical Plummets 5.04% Intraday on Price Target Cut and Product Recalls</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Intuitive Surgical Plummets 5.04% Intraday on Price Target Cut and Product Recalls\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-28 00:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Intuitive Surgical's stock plummeted 5.04% during intraday trading on Wednesday, as the medical device company faced dual headwinds from analyst downgrades and product safety concerns.</p><p>The decline followed Goldman Sachs lowering its price target on Intuitive Surgical to $558 from $621, representing a reduction of approximately 10%, while maintaining a Buy rating on the shares. The average analyst price target for the stock stands at $575.70 with an overweight rating, according to FactSet data.</p><p>Simultaneously, the company is grappling with multiple ongoing voluntary product recalls affecting its da Vinci surgical systems. The U.S. FDA announced a Class I recall of SureForm 30 Gray Reloads due to incomplete staple lines, impacting products distributed both domestically and internationally. Additional recalls involve certain da Vinci X and Xi system sub-components over concerns about screws breaking within the arm sub-assembly, raising questions about product reliability and future regulatory oversight.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ISRG","symbol_name":"直觉外科公司","start_time":0,"source_url":"","article_id":"1174731879","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1174731879","pubTimestamp":1779899707,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Intuitive Surgical's stock plummeted 5.04% during intraday trading on Wednesday, as the medical device company faced dual headwinds from analyst downgrades and product safety concerns.The decline...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ISRG":"直觉外科公司"},"translate_title":"个股追踪|Intuitive Surgical盘中暴跌5.04%受目标价下调及产品召回影响","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISRG":1},"content_text":"Intuitive Surgical's stock plummeted 5.04% during intraday trading on Wednesday, as the medical device company faced dual headwinds from analyst downgrades and product safety concerns.The decline followed Goldman Sachs lowering its price target on Intuitive Surgical to $558 from $621, representing a reduction of approximately 10%, while maintaining a Buy rating on the shares. The average analyst price target for the stock stands at $575.70 with an overweight rating, according to FactSet data.Simultaneously, the company is grappling with multiple ongoing voluntary product recalls affecting its da Vinci surgical systems. The U.S. FDA announced a Class I recall of SureForm 30 Gray Reloads due to incomplete staple lines, impacting products distributed both domestically and internationally. Additional recalls involve certain da Vinci X and Xi system sub-components over concerns about screws breaking within the arm sub-assembly, raising questions about product reliability and future regulatory oversight.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1174731879","isCrawlerRequest":true}